Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 4:26 pm Sale | 2023-12-31 | 13G | Replimune Group, Inc. REPL | Redmile Group LLC | 4,604,483 7.400% | -1,135,616 (-19.78%) | Filing History |
| 2024-02-14 4:26 pm Sale | 2023-12-31 | 13G | Neurogene Inc. NGNE | Redmile Group LLC | 1,050,304 8.100% | -232,357 (-18.12%) | Filing History |
| 2024-02-14 4:26 pm Sale | 2023-12-31 | 13G | ImmunoGen, Inc. IMGN | Redmile Group LLC | 16,423,922 5.900% | -3,472,531 (-17.45%) | Filing History |
| 2024-02-14 4:26 pm Sale | 2023-12-31 | 13G | Amicus Therapeutics, Inc. FOLD | Redmile Group LLC | 21,957,926 7.300% | -6,641,568 (-23.22%) | Filing History |
| 2024-02-14 4:26 pm Sale | 2023-12-31 | 13G | Advaxis, Inc. ADXS | Redmile Group LLC | 211,014 1.900% | -121,339 (-36.51%) | Filing History |
| 2024-02-14 4:26 pm Purchase | 2023-12-31 | 13G | Scholar Rock Holding Corporation SRRK | Redmile Group LLC | 7,706,883 9.900% | 2,205,494 (+40.09%) | Filing History |
| 2024-02-14 4:26 pm Purchase | 2023-12-31 | 13G | RAPT Therapeutics, Inc. RAPT | Redmile Group LLC | 3,776,847 9.900% | 97,009 (+2.64%) | Filing History |
| 2024-02-14 4:26 pm Purchase | 2023-12-31 | 13G | Nurix Therapeutics, Inc. NRIX | Redmile Group LLC | 5,021,886 9.900% | 122,114 (+2.49%) | Filing History |
| 2024-02-14 4:26 pm Purchase | 2023-12-31 | 13G | GRITSTONE BIO INC GRTSQ | Redmile Group LLC | 10,135,388 9.900% | 1,652,066 (+19.47%) | Filing History |
| 2024-02-14 4:26 pm Purchase | 2023-12-31 | 13G | Deciphera Pharmaceuticals, Inc. DCPH | Redmile Group LLC | 8,359,768 9.900% | 1,251,671 (+17.61%) | Filing History |
| 2024-02-14 4:26 pm Purchase | 2023-12-31 | 13G | Atara Biotherapeutics, Inc. ATRA | Redmile Group LLC | 412,056 9.900% | 18,557 (+4.72%) | Filing History |
| 2024-02-14 4:26 pm Purchase | 2023-12-31 | 13G | Annexon, Inc. ANNX | Redmile Group LLC | 8,083,776 9.900% | 3,186,201 (+65.06%) | Filing History |
| 2024-02-06 5:15 pm Purchase | 2024-02-02 | 13D | MedAvail Holdings, Inc. MDVLQ | Redmile Group LLC | 2,490,137 73.000% | 2,490,137 (New Position) | Filing History |
| 2024-01-31 5:15 pm Purchase | 2024-01-28 | 13D | Science 37 Holdings, Inc. SNCE | Redmile Group LLC | 994,529 16.500% | 994,529 (New Position) | Filing History |
| 2023-12-28 4:53 pm Sale | 2023-12-26 | 13D | Fate Therapeutics, Inc. FATE | Redmile Group LLC | 15,049,839 14.900% | -21,257 (-0.14%) | Filing History |
| 2023-12-26 4:15 pm Purchase | 2023-12-21 | 13D | Shattuck Labs, Inc. STTK | Redmile Group LLC | 5,664,892 12.000% | 44,978 (+0.80%) | Filing History |
| 2023-12-22 4:15 pm Purchase | 2023-12-18 | 13G | Neurogene Inc. NGNE | Redmile Group LLC | 1,282,661 9.900% | 1,282,661 (New Position) | Filing History |
| 2023-11-22 4:16 pm Purchase | 2023-11-20 | 13D | Augmedix, Inc. AUGX | Redmile Group LLC | 22,092,211 40.700% | 1,845,891 (+9.12%) | Filing History |
| 2023-11-17 5:15 pm Purchase | 2023-11-09 | 13G | REGENXBIO Inc. RGNX | Redmile Group LLC | 4,238,312 9.600% | 2,341,089 (+123.40%) | Filing History |
| 2023-10-16 5:15 pm Purchase | 2023-10-04 | 13G | ALX Oncology Holdings Inc. ALXO | Redmile Group LLC | 4,991,545 9.600% | 4,991,545 (New Position) | Filing History |